and get StockInvest.us Premium Subscription for FREE
Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Calithera Biosciences Stock Price (Quote) NASDAQ:CALA
$2.42 ( -1.63% ) Friday, 1st Jul 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.14 | $2.99 | Friday, 1st Jul 2022 CALA stock ended at $2.42. This is 1.63% less than the trading day before Thursday, 30th Jun 2022. During the day the stock fluctuated 4.56% from a day low at $2.41 to a day high of $2.52. |
| 90 days | $0.14 | $2.99 | |
| 52 weeks | $0.14 | $2.99 |
Historical Calithera Biosciences prices
| Date | Open | High | Low | Close | Volume |
| 2022-07-01 | $2.46 | $2.52 | $2.41 | $2.42 | 39 487 |
| 2022-06-30 | $2.50 | $2.59 | $2.39 | $2.46 | 47 500 |
| 2022-06-29 | $2.85 | $2.89 | $2.52 | $2.55 | 107 199 |
| 2022-06-28 | $2.85 | $2.99 | $2.76 | $2.86 | 51 831 |
| 2022-06-27 | $2.66 | $2.90 | $2.64 | $2.87 | 66 492 |
| 2022-06-24 | $2.64 | $2.74 | $2.54 | $2.60 | 96 856 |
| 2022-06-23 | $2.37 | $2.61 | $2.37 | $2.59 | 108 305 |
| 2022-06-22 | $2.41 | $2.50 | $2.37 | $2.41 | 94 366 |
| 2022-06-21 | $2.73 | $2.83 | $2.41 | $2.42 | 264 811 |
| 2022-06-17 | $2.57 | $2.85 | $2.57 | $2.70 | 184 969 |
| 2022-06-16 | $2.55 | $2.72 | $2.31 | $2.58 | 404 383 |
| 2022-06-15 | $2.46 | $2.81 | $2.34 | $2.75 | 346 262 |
| 2022-06-14 | $0.20 | $0.21 | $0.14 | $0.14 | 6 146 268 |
| 2022-06-13 | $0.22 | $0.23 | $0.20 | $0.20 | 1 656 374 |
| 2022-06-10 | $0.24 | $0.25 | $0.22 | $0.24 | 3 186 333 |
| 2022-06-09 | $0.23 | $0.25 | $0.22 | $0.24 | 3 614 397 |
| 2022-06-08 | $0.20 | $0.24 | $0.20 | $0.23 | 4 675 785 |
| 2022-06-07 | $0.21 | $0.22 | $0.19 | $0.20 | 6 938 008 |
| 2022-06-06 | $0.20 | $0.20 | $0.18 | $0.19 | 1 615 704 |
| 2022-06-03 | $0.20 | $0.21 | $0.19 | $0.20 | 1 486 045 |
| 2022-06-02 | $0.20 | $0.20 | $0.19 | $0.20 | 846 275 |
| 2022-06-01 | $0.20 | $0.21 | $0.20 | $0.20 | 1 041 393 |
| 2022-05-31 | $0.21 | $0.22 | $0.20 | $0.21 | 1 563 735 |
| 2022-05-27 | $0.20 | $0.21 | $0.19 | $0.21 | 2 731 463 |
| 2022-05-26 | $0.20 | $0.21 | $0.19 | $0.20 | 4 688 514 |
| 2022-05-25 | $0.20 | $0.22 | $0.18 | $0.20 | 4 628 790 |
| 2022-05-24 | $0.23 | $0.23 | $0.20 | $0.21 | 2 346 996 |
| 2022-05-23 | $0.22 | $0.24 | $0.22 | $0.22 | 1 600 493 |
| 2022-05-20 | $0.21 | $0.23 | $0.21 | $0.23 | 2 117 945 |
| 2022-05-19 | $0.18 | $0.22 | $0.18 | $0.21 | 3 348 144 |
| 2022-05-18 | $0.22 | $0.22 | $0.19 | $0.19 | 1 539 084 |
| 2022-05-17 | $0.23 | $0.23 | $0.20 | $0.22 | 3 773 621 |
| 2022-05-16 | $0.19 | $0.23 | $0.19 | $0.22 | 3 200 374 |
| 2022-05-13 | $0.20 | $0.23 | $0.18 | $0.23 | 20 435 398 |
| 2022-05-12 | $0.16 | $0.18 | $0.15 | $0.16 | 4 653 125 |
| 2022-05-11 | $0.21 | $0.21 | $0.16 | $0.16 | 7 847 922 |
| 2022-05-10 | $0.22 | $0.22 | $0.20 | $0.20 | 2 027 133 |
| 2022-05-09 | $0.23 | $0.24 | $0.20 | $0.20 | 3 192 274 |
| 2022-05-06 | $0.23 | $0.24 | $0.23 | $0.24 | 1 381 375 |
| 2022-05-05 | $0.26 | $0.26 | $0.23 | $0.24 | 3 240 576 |
| 2022-05-04 | $0.25 | $0.26 | $0.24 | $0.26 | 2 119 760 |
| 2022-05-03 | $0.25 | $0.26 | $0.24 | $0.25 | 1 770 727 |
| 2022-05-02 | $0.25 | $0.26 | $0.24 | $0.25 | 1 499 057 |
| 2022-04-29 | $0.26 | $0.27 | $0.23 | $0.25 | 2 782 048 |
| 2022-04-28 | $0.25 | $0.27 | $0.25 | $0.27 | 2 362 378 |
| 2022-04-27 | $0.25 | $0.26 | $0.25 | $0.25 | 1 278 556 |
| 2022-04-26 | $0.28 | $0.28 | $0.25 | $0.25 | 2 139 060 |
| 2022-04-25 | $0.32 | $0.32 | $0.26 | $0.28 | 5 495 428 |
| 2022-04-22 | $0.34 | $0.35 | $0.31 | $0.32 | 1 543 206 |
| 2022-04-21 | $0.37 | $0.40 | $0.34 | $0.36 | 23 671 000 |
Calithera Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate includes CB-839, an inhibitor of glutaminase, which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myelom... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
